WG
RXDX

Winton Group’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Winton Group’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,311
Closed -$431K – 1070
2022
Q3 		$431K Buy
+7,311
New +$431K 0.03% 683